US2005241941A1PendingUtilityA1

High throughput screening assay systems in microscale fluidic devices

Assignee: CALIPER LIFE SCIENCES INCPriority: Jun 28, 1996Filed: Jul 6, 2005Published: Nov 3, 2005
Est. expiryJun 28, 2016(expired)· nominal 20-yr term from priority
G01N 33/57515G01N 33/502B01L 2300/0861Y10T436/25Y10T436/11B01J 2219/00952Y10T436/110833B01J 2219/00853B01L 3/502784G01N 35/08G01N 33/5011B01J 2219/00961B01L 2300/0867B01L 2200/027B01J 2219/00828B01J 2219/0097Y10T436/117497B01L 2300/0877B01L 2400/0415B01L 2400/0487Y10S436/806G01N 33/5008B01L 3/502761B01J 2219/00831Y10S435/81B01L 3/5025B01L 2200/0668B01J 19/0093B01L 2300/0887G01N 33/5304Y10S366/02B01L 2200/0605B01L 2400/0418B01J 2219/00833G01N 33/5091B01L 2200/0673B01L 3/502753Y10T436/113332B01L 2300/0816Y10S435/817B01L 3/50273B01L 2300/0864Y10S436/805G01N 33/5097Y10S436/804B01L 2200/0647B01L 3/502715G01N 33/5064G01N 27/44791
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides novel microfluidic devices and methods that are useful for performing high-throughput screening assays. In particular, the devices and methods of the invention are useful in screening large numbers of different compounds for their effects on a variety of chemical, and preferably, biochemical systems.

Claims

exact text as granted — not AI-modified
1 . A microfluidic device, comprising: 
 means for continuously flowing interacting components of a biochemical system through a first of at least two intersecting channels;    means for flowing a test compound from a second channel into the first channel such that the test compound contacts at least one component of the biochemical system;    means for detecting an effect of the test compound on interactions of the components of the biochemical system.    
   
   
       2 . The microfluidic device of  claim 1 , wherein the components of a biochemical system comprise an enzyme and a substrate for the enzyme, and wherein action of the enzyme on the substrate produces a detectable signal.  
   
   
       3 . The microfluidic device of  claim 1 , wherein the components of a biochemical system comprise a receptor/ligand binding pair, wherein at least one of the receptor and the ligand has a detectable signal associated therewith.  
   
   
       4 . The microfluidic device of  claim 1 , wherein the components of a biochemical system comprise a receptor/ligand binding pair, wherein binding of the receptor to the ligand produces a detectable signal.  
   
   
       5 . The microfluidic device of  claim 1 , wherein the components of a biochemical system comprise components of a cell, and wherein the cell is capable of producing a detectable signal corresponding to a cellular function.  
   
   
       6 . The microfluidic device of  claim 5 , wherein detecting an effect of the test compound on interactions of the components of the cell comprises detecting an effect of the test compound on viability of the cell.  
   
   
       7 . The microfluidic device of  claim 1 , wherein the components of the biochemical system produce a flowable detectable signal representative of a function of the biochemical system.  
   
   
       8 . The microfluidic device of  claim 1 , wherein the detectable effect of the test compound on interactions of the components of the biochemical system comprises a change in a steady-state signal.  
   
   
       9 . The microfluidic device of  claim 1 , wherein at least one of the at least two intersecting channels has a cross-sectional dimension in a range from 0.1 μm to 500 μm.  
   
   
       10 . A microfluidic device, comprising: 
 means for continuously flowing interacting components of a biochemical system through a plurality of channels;    means for introducing a discrete volume of one of a plurality of test compounds into each of the plurality of channels such that the test compound contacts at least one component of the biochemical system; and    means for detecting an effect of each test compound on interactions of the components of the biochemical system.    
   
   
       11 . The microfluidic device of  claim 10 , wherein the components of a biochemical system comprise an enzyme and a substrate for the enzyme, and wherein action of the enzyme on the substrate produces a detectable signal.  
   
   
       12 . The microfluidic device of  claim 10 , wherein the components of a biochemical system comprise a receptor/ligand binding pair, wherein at least one of the receptor and the ligand has a detectable signal associated therewith.  
   
   
       13 . The microfluidic device of  claim 10 , wherein the components of a biochemical system comprise a receptor/ligand binding pair, wherein binding of the receptor to the ligand produces a detectable signal.  
   
   
       14 . The microfluidic device of  claim 10 , wherein the components of a biochemical system comprise components of a cell, and wherein the cell is capable of producing a detectable signal corresponding to a cellular function.  
   
   
       15 . The microfluidic device of  claim 14 , wherein detecting an effect of the test compound on interactions of the components of the cell comprises detecting an effect of the test compound on viability of the cell.  
   
   
       16 . The microfluidic device of  claim 10 , wherein the components of the biochemical system produce a flowable detectable signal representative of a function of the biochemical system.  
   
   
       17 . The microfluidic device of  claim 10 , wherein the detectable effect of the test compound on interactions of the components of the biochemical system comprises a change in a steady-state signal.  
   
   
       18 . The microfluidic device of  claim 10 , wherein at least one of the plurality of channels has a cross-sectional dimension in a range from 0.1 μm to 500 μm.  
   
   
       19 . A microfluidic test compound processing system, comprising: 
 means for holding a microfluidic device;    means for continually flowing components of a biochemical system in a first of at least two intersecting channels within the microfluidic device;    means for introducing a test compound into the microfluidic device from an external test compound source;    means for placing the introducing means in fluid communication with the external test compound source;    means for controlling flow and direction of the test compound within the microfluidic device such that the test compound contacts at least one of the continually flowing components of the biochemical system; and    means for detecting an effect of the test compound on interactions of the components of the biochemical system.    
   
   
       20 . The microfluidic test compound processing system of  claim 19 , wherein at least one of the at least two intersecting channels has a cross-sectional dimension in a range from 0.1 μm to 500 μm.

Join the waitlist — get patent alerts

Track US2005241941A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.